Foundation Advisor Christine Berg Makes Case for Rethinking Lung Cancer Screening Policy
Dr. Christine Berg, who led the trial that shaped today's lung cancer screening guidelines, argues it's time for policy to catch up with the science.
July 28, 2026
.png)
Christine D. Berg, M.D., Senior Clinical Advisor to the Susan Wojcicki Foundation, published a guest commentary in The Cancer Letter making the case for why U.S. lung cancer screening policy needs to evolve as quickly as the science does.
Dr. Berg led the National Lung Screening Trial (NLST), the study that established the eligibility criteria most U.S. screening guidelines still use today: a history of heavy smoking within a defined age range.
In her essay, Dr. Berg traces how those criteria, while appropriate based on the evidence generated by the trial at the time, have left a growing share of lung cancer patients without a path to early detection, including an increasing number of people who have never smoked. In fact, an analysis she conducted in 2012 with her National Cancer Institute colleague Paul Pinsky found that less than a third of U.S. lung cancer patients would have been eligible for screening under the original NLST criteria.
This shows why it’s so important to expand screening guidelines: We can help more people detect lung cancer earlier, when it is most treatable.
Read the full op-ed in The Cancer Letter and learn more about our research priorities.
Related Posts
Susan Wojcicki Foundation Launches to Advance Early Detection and Prevention of Lung Cancer
The Foundation brings together leading partners across science, technology, and research, with early programs underway and significant first-year commitments from Google.org, Melinda French Gates, and Salesforce.
What an Oncologist Wants You to Know About Environmental Cancer Risks - Washington Post
From air pollution to microplastics to natural radiation, here’s what to be aware of — and what can reduce exposure.
.png)
TIME Magazine Explores Foundation’s Mission in New In-Depth Feature Story
In a new feature story on newsstands now, TIME explores how the Susan Wojcicki Foundation is working to understand the changing demographics of lung cancer diagnoses and accelerate research into early detection.